Nevertheless, we have recently shown that ILT2 is highly dysregulated in leukemic cells and CD8 and CD4 T cells of CLL patients, particularly in those patients having bad prognostic features, and it plays a significant role in the immunosuppression observed in those patients (35). This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.